Localized morphea in children

Advances in Experimental Medicine and Biology

Volumn 455, Issue , 1999, Pages 49-54

  Krafchik, B R ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; STEROID;

CHILD; CONFERENCE PAPER; DISEASE ACTIVITY; DRUG EFFECT; EPIDERMIS CELL; FEMALE; HUMAN; LEG LENGTHENING; LICHEN SCLEROSUS ET ATROPHICUS; MAJOR CLINICAL STUDY; MALE; MORPHEA; PATHOGENESIS; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

SCLERODERMA;

EID: 0033282337     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4857-7_7     Document Type: Conference Paper

References (11)

1. Historical approach to scleroderma
2. Subspecialty clinics:Rheumatology and dermatology. Classification of morphea (localized scleroderma)
3. Scleroderma and pseudoscleroderma. 2nd Ed.
4. Localized scleroderma associated with Borrelia burgdorferi infection
5. Childhood linear slceroderma - A possible role of thermography for evaluation
6. No evidence for a relation between Borrelia burgdorferi infection and old lesions of localized scleroderma (morphea)
7. Antinuclear antibodies in children with localized scleroderma
8. Antihistone antibodies in patients with localized scleroderma
9. Antinuclear antibodies in localized scleroderma
10. Localized scleroderma progressing to systemic disease. Case report and review of the literature
11. Serum levels of soluble interleukin-2 receptor. A marker of disease activity in localized scleroderma